Both Staphylococcus aureus and S. epidermidis are capable of forming biofilm on
biomaterials. We used Tn 917 mutagenesis to identify a gene, rbf, affecting biofilm formation …

We previously reported the identification of a gene, rbf, involved in the regulation of biofilm
formation by Staphylococcus aureus 8325-4. In an effort to study the mechanism of …

Biofilms contribute to virulence of Staphylococcus aureus. Formation of biofilms is
multifactorial, involving polysaccharide, protein, and DNA components, which are controlled …

The biofilm formation capacity of Staphylococcus aureus clinical isolates is considered an
important virulence factor for the establishment of chronic infections. Environmental …

We reported previously that low concentrations of sodium citrate strongly promote biofilm
formation by Staphylococcus aureus laboratory strains and clinical isolates. Here, we show …

Staphylococcus aureus clinical isolates are capable of producing at least two distinct types
of biofilm mediated by the fibronectin-binding proteins (FnBPs) or the icaADBC-encoded …

Device-associated infections involving biofilm remain a persistent clinical problem. We
recently reported that four methicillin-resistant Staphylococcus aureus (MRSA) strains …

Several serious diseases are caused by biofilm-associated Staphylococcus aureus,
infections in which the accessory gene regulator (agr) quorum-sensing system is thought to …

Staphylococcus epidermidis is a common pathogen in medical device-associated infections.
Its major pathogenetic factor is the ability to form adherent biofilms. The polysaccharide …

The production of Staphylococcus aureus virulence factors is under the control of complex
regulatory circuits. Most studies aimed at defining these regulatory networks have focused …